Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161116
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-11-29
Brief Title:
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus MK-6194-006
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-29
First Submit QC Date:
November 29 2023
Study First Post Date:
2023-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-17
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL